Patent details
300612
Product Name:
4-aminopyridine, dan wel een derivaat daarvan, in het bijzonder een zout, solvaat of prodrug.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300612
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2377536
Status:
Refused Art. 10 of the EC Regulations
Application number:
300612
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/11/699/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/07/2011
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
03/09/2013
First Marketing Authorization date:
20/07/2011
Grant date:
Activation date:
11/04/2025
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/10/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
27/01/2021
Applicant/holder
From:
03/09/2013
Name:
Acorda Therapeutics, Inc.
Address:
420 Saw Mill River Road, ARDSLEY, NY 10502, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
03/09/2013
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
04/21
Publication date:
27/01/2021
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
44/15
Publication date:
28/10/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
2013/38
Publication date:
18/09/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
27/01/2021
Outgoing Correspondence
Decision refusal
2
PDF
/2/1/6/0/0/0400300612/docs/300612_8_391798l527a.pdf
26/10/2020
Outgoing Correspondence
Letter to applicant
2
PDF
/2/1/6/0/0/0400300612/docs/300612_11_374401l173.pdf
31/05/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/2/1/6/0/0/0400300612/docs/300612_0_incomingcorrespondencepaper20160602115729637.pdf
31/05/2016
SPC Documents
Annex SPC
1
PDF
/2/1/6/0/0/0400300612/docs/300612_10_supplprotectioncertificate20200304104920192.pdf
03/06/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/1/6/0/0/0400300612/docs/300612_6_outgoingcorrespondence20140603.pdf
26/05/2014
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/2/1/6/0/0/0400300612/docs/300612_1_incomingcorrespondencepaper20140526.pdf
10/09/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/1/6/0/0/0400300612/docs/300612_4_outgoingcorrespondence20130910.pdf
09/09/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/1/6/0/0/0400300612/docs/300612_2_outgoingcorrespondence20130909.pdf
03/09/2013
Application Form
Confirmed application form
3
PDF
/2/1/6/0/0/0400300612/docs/300612_3_applicationform20130903.pdf
03/09/2013
SPC Documents
Summary of the characteristics of the product
12
PDF
/2/1/6/0/0/0400300612/docs/300612_5_supplprotectioncertificate20200304103747085.pdf
03/09/2013
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/2/1/6/0/0/0400300612/docs/300612_7_incomingcorrespondencepaper20130903.pdf
03/09/2013
SPC Documents
Marketing Authorization SPC
4
PDF
/2/1/6/0/0/0400300612/docs/300612_9_supplprotectioncertificate20200304104026241.pdf